GESTALT
348 posts

GESTALT
@GESTALT_sp
Global Alliance for Spatial Technologies: an organized whole that is perceived as more than the sum of its parts. Democratizing Spatial-Omics Techs





Introducing Spatial ATAC-TAPS+ Following our AGBT 2026 presentation, we're excited to share our poster introducing our dual-modality spatial assay — developed in collaboration with Watchmaker Genomics, Matija Snuderl, and Ultima Genomics. Spatial ATAC-TAPS+ integrates chromatin accessibility and DNA methylation (5mC & 5hmC) profiling within the same tissue section, revealing regulatory heterogeneity that bulk assays miss. 📄 View the full poster: lnkd.in/e9MAiveY 🔬 Explore Spatial ATAC-TAPS+ and our broader spatial epigenomic platform at AtlasXomics.com #AGBT2026 #SpatialEpigenomics #DNAMethylation #ChromatinAccessibility

Can mitochondrial DNA accurately recover cell ancestry? Delighted to share MitoDrift—using population genetics to turn noisy mtDNA heteroplasmy into high-precision #singlecell lineage trees: doi.org/10.64898/2026.… Joint with @chenweng1991, from the labs of @bloodgenes + @JswLab


𝗕𝗲𝗻𝗰𝗵𝗺𝗮𝗿𝗸𝗶𝗻𝗴 𝗶𝘀 𝗕𝗿𝗼𝗸𝗲𝗻. 𝗟𝗲𝘁’𝘀 𝗙𝗶𝘅 𝗜𝘁. Single-cell and spatial benchmarking studies dominate journals and conferences. Yet, after the leaderboards are published, you’re still left with the same high-stakes questions: Do these metrics actually inform your next biological move, or just confirm what you already know? When the grant money is on the line, the question isn't just 'what works' - it’s 'what works within reach.' Which platform truly maximizes biological output for your specific budget? Most benchmarking work misses the point. It ranks tools. It crowns winners. But it leaves you to carry the risk when it’s time to design your study and spend your grant. 𝗠𝗼𝘃𝗶𝗻𝗴 𝗕𝗲𝘆𝗼𝗻𝗱 𝘁𝗵𝗲 𝗟𝗲𝗮𝗱𝗲𝗿𝗯𝗼𝗮𝗿𝗱 At AGBT 2026, four of our beloved leaders in the field will challenge the status quo of benchmarking. We aren't talking about which method "wins" or who runs the fastest pipeline. We are questioning the utility of the metrics themselves. This discussion will dive into the hard truths of study design: -𝗜𝗻𝘀𝗶𝗴𝗵𝘁 𝘃𝘀. 𝗠𝗲𝘁𝗿𝗶𝗰𝘀: are you optimizing for biological discovery or just "clean" data? -𝗥𝗲𝗮𝗹𝗶𝘁𝘆 𝘃𝘀. 𝗜𝗱𝗲𝗮𝗹𝗶𝘀𝗺: are you planning studies real labs can afford, or chasing extreme depth that isn't reproducible? -𝗚𝘂𝗶𝗱𝗮𝗻𝗰𝗲 𝘃𝘀. 𝗛𝘆𝗽𝗲: are benchmarks helping you design better experiments or simply feeding a hype cycle? 𝗝𝗼𝗶𝗻 𝘁𝗵𝗲 𝗖𝗼𝗻𝘃𝗲𝗿𝘀𝗮𝘁𝗶𝗼𝗻 If you generate or analyze single-cell or spatial data, this panel will speak directly to your results and your bottom line. Details coming soon. Stay tuned! #Benchmarking #SingleCell #MultiOmics #Bioinformatics #Genomic #SpatialBiology #AGBT2026


We’re thrilled that @DrJasPlummer, (Founding Director, Center for Spatial OMICs, St Jude Children's Research Hospital) is speaking at The Festival of Genomics and Biodata! She’ll focus on #spatial profiling at scale. More info: hubs.la/Q03ZBNB20 #FOG2026






I remember seeing the very first tests in this magical work… Amazing science from @KleinLabHMS Multistep genomics on single cells and live cultures in subnanoliter capsules | Science science.org/doi/10.1126/sc…






